ERBB4
ERBB4 also known as v-erb-a erythroblastic leukemia viral oncogene homolog 4 is a protein that in humans is encoded by the ERBB4 gene. ERBB4 is a member of the Epidermal Growth Factor Receptor (EGFR) family, which is part of the Receptor Tyrosine Kinase (RTK) superfamily. The EGFR family consists of four members: EGFR (also known as ERBB1), ERBB2 (also known as HER2/neu), ERBB3 (also known as HER3), and ERBB4 (also known as HER4). These receptors play critical roles in various cellular processes, including cell proliferation, differentiation, and survival, and have been implicated in the development and progression of many types of cancer.
Function[edit]
ERBB4 functions as a receptor for the neuregulins, NRG1 and NRG2, and other ligands such as betacellulin. Upon ligand binding, ERBB4 undergoes homodimerization or heterodimerization with other EGFR family members, leading to the activation of several signal transduction pathways, including the PI3K/AKT pathway, the MAPK pathway, and the Phospholipase C (PLC) pathway. These pathways are involved in regulating various cellular responses such as gene expression, cell growth, and apoptosis.
Clinical Significance[edit]
Alterations in the ERBB4 gene, including mutations and overexpression, have been associated with several types of cancer, including breast cancer, ovarian cancer, and melanoma. ERBB4 has been identified as a potential therapeutic target, and drugs that specifically target ERBB4 or its downstream signaling pathways are being developed and tested in clinical trials.
In addition to its role in cancer, ERBB4 signaling is important for heart development and function, and mutations in the ERBB4 gene have been linked to congenital heart defects. ERBB4 is also involved in the development and function of the nervous system, including neuronal survival, synapse formation, and neurotransmitter release.
Genetics[edit]
The ERBB4 gene is located on the long arm of chromosome 17 (17q12). It consists of multiple exons that can undergo alternative splicing, resulting in various isoforms of the ERBB4 protein that differ in their cytoplasmic domains and have different biological activities.
See Also[edit]
References[edit]
<references/>
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
